| 000 | 01625 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518003250.0 | ||
| 264 | 0 | _c20191216 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a2531-6745 | ||
| 024 | 7 |
_a10.23750/abm.v89i3.7718 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZignego, Anna Linda | |
| 245 | 0 | 0 |
_aSofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection. _h[electronic resource] |
| 260 |
_bActa bio-medica : Atenei Parmensis _c10 2018 |
||
| 300 |
_a321-331 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFatigue _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 4 or More Rings _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aNasopharyngitis _xchemically induced |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aPain _xchemically induced |
| 650 | 0 | 4 | _aPatient Reported Outcome Measures |
| 650 | 0 | 4 |
_aSofosbuvir _xadministration & dosage |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMonti, Monica | |
| 700 | 1 | _aGragnani, Laura | |
| 773 | 0 |
_tActa bio-medica : Atenei Parmensis _gvol. 89 _gno. 3 _gp. 321-331 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.23750/abm.v89i3.7718 _zAvailable from publisher's website |
| 999 |
_c28951231 _d28951231 |
||